Angiotensin AT1/AT2 receptors: regulation, signalling and function.
about
Angiotensin II in inflammation, immunity and rheumatoid arthritisRational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptorsPathophysiology of Heart Failure.Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressure.Development of selective non-peptide angiotensin II type 2 receptor agonists.Anteroposterior distribution of AT(1) angiotensin receptors in caudal brainstem cardiovascular regulatory centers of the ratInhibition of NAD(P)H oxidase potentiates AT2 receptor agonist-induced natriuresis in Sprague-Dawley rats.Responses to dehydration in the one-humped camel and effects of blocking the renin-angiotensin systemOxidative stress alters renal D1 and AT1 receptor functions and increases blood pressure in old rats.Angiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs.Developmental changes in AT1 and AT2 receptor-protein expression in ratsMitochondrial aldehyde dehydrogenase prevents ROS-induced vascular contraction in angiotensin-II hypertensive mice.Effects of dehydration and blockade of angiotensin II AT1 receptor on stress hormones and anti-oxidants in the one-humped camelTranscriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.Angiotensin II increases activity of the epithelial Na+ channel (ENaC) in distal nephron additively to aldosterone.An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations.Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.Chronic NF-κB blockade improves renal angiotensin II type 1 receptor functions and reduces blood pressure in Zucker diabetic rats.Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious ratsCombined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies.ARBs and target organ protection. Exploring benefits beyond their antihypertensive effects.Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic herniaAngiotensin-II mediates nonmuscle myosin II activation and expression and contributes to human keloid disease progressionClassification of scaffold-hopping approachesAltered functioning of both renal dopamine D1 and angiotensin II type 1 receptors causes hypertension in old rats.Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes.Obstructive nephropathy: insights from genetically engineered animals.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.Ontogeny of angiotensin type 2 and type 1 receptor expression in mice.Role of angiotensin II receptor blockers in atherosclerotic plaque stability.Angiotensin II and III metabolism and effects on steroid production in the HAC15 human adrenocortical cell lineThe Prorenin and (Pro)renin Receptor: New Players in the Brain Renin-Angiotensin System?Direct activation of ENaC by angiotensin II: recent advances and new insights.Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy.Localisation of renin-angiotensin system (RAS) components in breast.Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan.Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial.
P2860
Q26991828-B36A58AD-343F-48D3-A5B7-D8BA1477B236Q27023787-5DE25766-4D4D-4CB4-B057-F92DE4A6ABD4Q30315815-9EF16512-F7D5-46F8-9511-5FCFDF1A5D00Q30492950-23BCDAB6-BEBD-417D-BCD7-E7A7D983F180Q33389012-07FDCC7A-1704-4295-8977-CF1E0D3AC19BQ33514251-CBFAE932-15D7-4392-A0CF-136EDA05793CQ33562011-AB6C470A-53F6-4297-8F3B-A8BCDEC8900AQ34211604-460437A7-CCE7-4275-9D93-55B0F5D7FFF0Q34279890-7CCCED8E-6660-4AAF-A736-B4726013F0B7Q34501887-EFEBFC36-3764-48AA-B4A9-8F985BEE2C3AQ34555953-80740123-F3EB-40F6-B6FC-7A009D3DC7A5Q34557839-27D3AE52-D9E3-4BC8-B4A3-EDFD43EB5514Q34899768-49B175C0-358E-4632-B89D-B05CF16D206CQ35047044-B467ABBC-3400-42FF-8C04-7E3660819F27Q35388346-5FC410FF-E08A-4951-AC7E-8D380B9329ABQ35484295-B6277326-6919-49E2-8863-CE36EBE78840Q35643832-ABC801B1-11BA-4B67-9636-083080B555F5Q35720141-0E107653-B17F-4FFD-BBFA-A48761FE5E6DQ35726197-1F296F72-F401-4608-BA2B-BF2490E71760Q35736816-43A917D9-BC9C-4E28-A598-493BD86A49A4Q35777568-A0F2B518-0EF1-486B-BFC4-8FBC135AF4A0Q35828486-956AFE24-19A9-422F-BAE4-185926C277F5Q35868228-094836BD-DB9D-42BF-9445-E78D906928B5Q35872512-C2D7F0A9-0534-4D84-B91A-12F52CB4742EQ35876800-E7307F54-4999-4325-8944-518483075E79Q35893996-A18B3F1C-6627-400F-8608-3B6398AE171DQ35903294-718A11FF-F3D7-4B0E-8E5B-609C7A48B0F3Q36160619-35FAB799-9D03-4EBF-9770-47CE9D281D2DQ36232250-4862FD69-9ACA-42D7-860A-6FCA79522291Q36241932-46ABC48D-38EA-4FF6-A7FC-7BBCBF5FC8C1Q36257966-0EFE77D9-961A-4AB4-90DA-8A67AE333582Q36296584-C8A8F934-2FE8-421A-B488-F749690F0652Q36382568-4A9A2EC5-2105-414D-870E-B102B2F445BCQ36486125-B613AFA4-F3F6-4705-9BE8-E34A31E180FDQ36506655-C5D0251A-CB49-4A85-B0F3-34E817B85341Q36532749-71636663-642A-4558-B44E-DEC4D0FDB968Q36540314-0634E50C-4C54-4198-9A3B-138E2AA870F4Q36611557-C8A03577-B871-45EF-B33B-FB189801B3BFQ36642651-C16C6CDE-FE83-4146-9990-159634124E3EQ36716415-38BE2625-0B4E-4AB5-99A4-8F6C0E8A483A
P2860
Angiotensin AT1/AT2 receptors: regulation, signalling and function.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Angiotensin AT1/AT2 receptors: regulation, signalling and function.
@ast
Angiotensin AT1/AT2 receptors: regulation, signalling and function.
@en
type
label
Angiotensin AT1/AT2 receptors: regulation, signalling and function.
@ast
Angiotensin AT1/AT2 receptors: regulation, signalling and function.
@en
prefLabel
Angiotensin AT1/AT2 receptors: regulation, signalling and function.
@ast
Angiotensin AT1/AT2 receptors: regulation, signalling and function.
@en
P1433
P1476
Angiotensin AT1/AT2 receptors: regulation, signalling and function.
@en
P356
10.1080/08037050310001057
P577
2003-01-01T00:00:00Z